MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 9 | 0.0 |
Animals | 12 | 0.0 |
Base Sequence | 15 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Gene Expression | 2 | 0.0 |
Humans | 70 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Molecular Weight | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 32 | 0.0 |
Transfection | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
DNA Helicases/metabolism | 2 | 7.0 |
*DNA Replication | 3 | 1.0 |
DNA, Single-Stranded/*metabolism | 7 | 25.0 |
DNA, Viral/*biosynthesis | 3 | 15.0 |
Mice | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Replication Origin | 3 | 12.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
Adult | 21 | 0.0 |
Aged | 12 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Antibodies, Antinuclear/blood | 4 | 8.0 |
Disease Progression | 2 | 0.0 |
Female | 26 | 0.0 |
Male | 19 | 0.0 |
Middle Aged | 17 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
*DNA Damage | 6 | 1.0 |
DNA Repair | 2 | 0.0 |
Autoantibodies/*blood | 3 | 1.0 |
Case-Control Studies | 2 | 0.0 |
Hela Cells | 9 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
DNA Damage | 2 | 0.0 |
DNA, Single-Stranded/metabolism | 4 | 6.0 |
DNA-Binding Proteins/*metabolism | 12 | 0.0 |
*Recombination, Genetic | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 3 | 0.0 |
Anti-Inflammatory Agents/therapeutic use | 2 | 2.0 |
Comparative Study | 10 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Rheumatoid Factor/blood | 2 | 5.0 |
Risk Factors | 2 | 0.0 |
Statistics, Nonparametric | 2 | 0.0 |
Adolescent | 6 | 0.0 |
Antibodies, Antinuclear/*blood | 3 | 25.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Prospective Studies | 2 | 0.0 |
Escherichia coli/metabolism | 3 | 1.0 |
English Abstract | 4 | 0.0 |
Biopsy | 2 | 0.0 |
Biological Markers/blood | 2 | 0.0 |
Child | 3 | 0.0 |
Crystallography, X-Ray | 3 | 0.0 |
Dimerization | 3 | 0.0 |
Rats | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Cell Survival/drug effects | 2 | 0.0 |
Deuterium | 2 | 7.0 |
Hamsters | 3 | 0.0 |
Kinetics | 7 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
Immunodiffusion | 2 | 0.0 |
Hydrogen-Ion Concentration | 4 | 0.0 |
Sjogren's Syndrome/blood/*immunology | 2 | 22.0 |
Escherichia coli/*chemistry | 2 | 25.0 |
Mitochondria/*chemistry | 2 | 33.0 |
Protein Conformation | 2 | 0.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Structure, Quaternary | 2 | 1.0 |
Scattering, Radiation | 2 | 1.0 |
Enzyme Activation | 2 | 0.0 |
DNA Replication | 3 | 0.0 |
Gene Expression Regulation, Viral | 2 | 0.0 |
Plasmids | 4 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Macromolecular Substances | 5 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Child, Preschool | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
Immunoglobulin G/analysis | 2 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Sjogren's Syndrome/*diagnosis | 2 | 40.0 |
Saccharomyces cerevisiae/*genetics/metabolism | 2 | 4.0 |
Chemistry, Physical | 3 | 2.0 |
Microscopy, Electron | 2 | 0.0 |
Spectrometry, Fluorescence | 2 | 0.0 |
Chromatography | 4 | 2.0 |
Nucleic Acid Conformation | 3 | 0.0 |
Centrifugation, Density Gradient | 3 | 0.0 |
Chromatography, Affinity | 2 | 0.0 |
Chromatography, Ion Exchange | 2 | 0.0 |
DNA/metabolism | 3 | 0.0 |
Durapatite | 2 | 11.0 |
Hydroxyapatites | 2 | 14.0 |
Antibodies, Antinuclear/*analysis | 3 | 11.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Lupus Erythematosus, Systemic/immunology | 3 | 2.0 |
Mixed Connective Tissue Disease/immunology | 3 | 75.0 |
Rheumatic Diseases/*immunology | 2 | 12.0 |
Scleroderma, Systemic/immunology | 2 | 22.0 |
Sjogren's Syndrome/immunology | 3 | 17.0 |
DNA Repair/*genetics | 2 | 0.0 |
DNA-Directed DNA Polymerase/*metabolism | 2 | 7.0 |
Infant, Newborn | 2 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
*DNA Repair | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Cytarabine/pharmacology | 2 | 4.0 |
DNA, Single-Stranded/*drug effects | 2 | 28.0 |
Connective Tissue Diseases/*immunology | 2 | 15.0 |
Genotype | 2 | 0.0 |
Eating | 2 | 1.0 |
Electromyography | 4 | 2.0 |
Colon/*physiopathology | 2 | 100.0 |
Colonic Diseases, Functional/*physiopathology | 2 | 66.0 |
